Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Military Report Slams DMAA While GNC Claims Victory

This article was originally published in The Tan Sheet

Executive Summary

A Department of Defense safety review panel does not find a conclusive causal association between DMAA and adverse events, including four service members’ deaths, a conclusion that “delighted” retailer GNC. But DoD’s ban on sales of DMAA products in military exchanges and concessions remains in place.

You may also be interested in...

NSF ‘Certified For Sport’ Apps Cuts Through Unsafe Supplement Clutter

NSF International introduces Certified for Sport app to identify its 700 certified supplement products by scanning a product barcode and also connect to brands' e-commerce site. Since a hard launch in late January, NSF says downloads are “in the thousands.”

DMAA, Other Stimulants Cast Shadow Over FDA Supplement Regulation – Study

Six workout and weight loss brands contained DMAA and three other stimulants, according to a study in the Journal Clinical Toxicology. Researchers concluded consumers must be informed of risk so they know to check labels for three substances that indicate the presence of the stimulants.

FTC Shares Doubts About Supplements, Ad Claims In Its Consumer Library

FTC announces an addition to its library of consumer information with on supplements. It also notes online initiative by the Consortium for Health and Military Performance at the Uniformed Services University of the Health Sciences "mostly intended for the military community" but also relevant to other consumers.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts